| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | procollagen galactosyltransferase activity | 6.31e-06 | 4 | 21 | 2 | GO:0050211 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.42e-04 | 17 | 21 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | UDP-galactosyltransferase activity | 5.13e-04 | 32 | 21 | 2 | GO:0035250 | |
| GeneOntologyMolecularFunction | galactosyltransferase activity | 6.14e-04 | 35 | 21 | 2 | GO:0008378 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.34e-03 | 211 | 21 | 3 | GO:0016758 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.44e-03 | 70 | 21 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.26e-03 | 288 | 21 | 3 | GO:0016757 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.76e-03 | 118 | 21 | 2 | GO:0003774 | |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 1.78e-05 | 6 | 23 | 2 | GO:1990049 | |
| GeneOntologyBiologicalProcess | anterograde neuronal dense core vesicle transport | 3.32e-05 | 8 | 23 | 2 | GO:1990048 | |
| GeneOntologyBiologicalProcess | proteoglycan catabolic process | 6.50e-05 | 11 | 23 | 2 | GO:0030167 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 7.80e-05 | 12 | 23 | 2 | GO:0099519 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.07e-05 | 76 | 23 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 1.07e-04 | 14 | 23 | 2 | GO:1901950 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to vascular endothelial growth factor stimulus | 2.01e-04 | 19 | 23 | 2 | GO:1902548 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 1 type immune response | 2.23e-04 | 20 | 23 | 2 | GO:0002827 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 3.23e-04 | 24 | 23 | 2 | GO:0008090 | |
| Domain | Glyco_trans_25 | 4.74e-06 | 3 | 24 | 2 | IPR002654 | |
| Domain | Glyco_transf_25 | 4.74e-06 | 3 | 24 | 2 | PF01755 | |
| Domain | Kinesin_assoc | 2.37e-05 | 6 | 24 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 2.37e-05 | 6 | 24 | 2 | IPR032405 | |
| Domain | DUF1220 | 5.67e-05 | 9 | 24 | 2 | SM01148 | |
| Domain | NBPF | 8.64e-05 | 11 | 24 | 2 | PS51316 | |
| Domain | DUF1220 | 8.64e-05 | 11 | 24 | 2 | PF06758 | |
| Domain | NBPF_dom | 8.64e-05 | 11 | 24 | 2 | IPR010630 | |
| Domain | FHA | 5.86e-04 | 28 | 24 | 2 | SM00240 | |
| Domain | FHA_DOMAIN | 7.19e-04 | 31 | 24 | 2 | PS50006 | |
| Domain | FHA | 7.19e-04 | 31 | 24 | 2 | PF00498 | |
| Domain | FHA_dom | 9.71e-04 | 36 | 24 | 2 | IPR000253 | |
| Domain | - | 9.71e-04 | 36 | 24 | 2 | 2.60.200.20 | |
| Domain | Kinesin_motor_CS | 1.26e-03 | 41 | 24 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 1.38e-03 | 43 | 24 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.45e-03 | 44 | 24 | 2 | PS00411 | |
| Domain | - | 1.45e-03 | 44 | 24 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.45e-03 | 44 | 24 | 2 | IPR001752 | |
| Domain | Kinesin | 1.45e-03 | 44 | 24 | 2 | PF00225 | |
| Domain | KISc | 1.45e-03 | 44 | 24 | 2 | SM00129 | |
| Domain | KINESIN_MOTOR_2 | 1.45e-03 | 44 | 24 | 2 | PS50067 | |
| Domain | ER_TARGET | 1.65e-03 | 47 | 24 | 2 | PS00014 | |
| Domain | - | 1.72e-03 | 48 | 24 | 2 | 2.120.10.80 | |
| Domain | SMAD_FHA_domain | 2.02e-03 | 52 | 24 | 2 | IPR008984 | |
| Domain | Kelch-typ_b-propeller | 2.25e-03 | 55 | 24 | 2 | IPR015915 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.59e-03 | 59 | 24 | 2 | IPR011043 | |
| Domain | TSP_1 | 2.95e-03 | 63 | 24 | 2 | PF00090 | |
| Domain | TSP1 | 3.13e-03 | 65 | 24 | 2 | SM00209 | |
| Domain | TSP1_rpt | 3.13e-03 | 65 | 24 | 2 | IPR000884 | |
| Domain | TSP1 | 3.13e-03 | 65 | 24 | 2 | PS50092 | |
| Domain | - | 4.82e-03 | 81 | 24 | 2 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 5.66e-03 | 88 | 24 | 2 | IPR029044 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 30822656 | ||
| Pubmed | Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases. | 4.96e-07 | 2 | 25 | 2 | 19075007 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23404705 | ||
| Pubmed | 1.39e-05 | 8 | 25 | 2 | 2341393 | ||
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.39e-05 | 8 | 25 | 2 | 25818806 | |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 3.26e-05 | 12 | 25 | 2 | 22906538 | |
| Pubmed | 5.86e-05 | 105 | 25 | 3 | 24667918 | ||
| Pubmed | Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. | 6.70e-05 | 17 | 25 | 2 | 9175833 | |
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 1.03e-04 | 21 | 25 | 2 | 27287879 | |
| Pubmed | 1.03e-04 | 21 | 25 | 2 | 16079250 | ||
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 1.47e-04 | 25 | 25 | 2 | 2283726 | |
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 1.47e-04 | 25 | 25 | 2 | 9275178 | |
| Pubmed | 1.60e-04 | 26 | 25 | 2 | 8218172 | ||
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 3.25e-04 | 37 | 25 | 2 | 11416179 | |
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 5.04e-04 | 46 | 25 | 2 | 2649653 | |
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 5.26e-04 | 47 | 25 | 2 | 14760718 | |
| Interaction | COLQ interactions | 6.93e-06 | 33 | 23 | 3 | int:COLQ | |
| Interaction | UGGT2 interactions | 1.05e-04 | 81 | 23 | 3 | int:UGGT2 | |
| Interaction | PCYOX1 interactions | 1.12e-04 | 83 | 23 | 3 | int:PCYOX1 | |
| Interaction | ENTPD5 interactions | 1.30e-04 | 15 | 23 | 2 | int:ENTPD5 | |
| Interaction | COL6A2 interactions | 1.43e-04 | 90 | 23 | 3 | int:COL6A2 | |
| Cytoband | 1q25 | 9.18e-05 | 26 | 25 | 2 | 1q25 | |
| Cytoband | 1p13.3 | 6.53e-04 | 69 | 25 | 2 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 2.61e-03 | 139 | 25 | 2 | chr5p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 5.88e-03 | 211 | 25 | 2 | chr1p13 | |
| GeneFamily | Collagen beta(1-O)galactosyltransferases | 1.28e-06 | 2 | 21 | 2 | 439 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.20e-04 | 23 | 21 | 2 | 662 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.29e-03 | 46 | 21 | 2 | 622 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.01e-05 | 369 | 23 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 5.22e-05 | 194 | 23 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 7.58e-05 | 422 | 23 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 1.31e-04 | 92 | 23 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_500 | 1.78e-04 | 102 | 23 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.56e-04 | 293 | 23 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.96e-08 | 199 | 25 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.16e-08 | 200 | 25 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.16e-08 | 200 | 25 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 8.16e-08 | 200 | 25 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 169 | 25 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-06 | 175 | 25 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 178 | 25 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-06 | 180 | 25 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-06 | 180 | 25 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-06 | 181 | 25 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-06 | 181 | 25 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 184 | 25 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.27e-06 | 185 | 25 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.41e-06 | 187 | 25 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-06 | 187 | 25 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.41e-06 | 187 | 25 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.41e-06 | 187 | 25 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.56e-06 | 189 | 25 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 189 | 25 | 4 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 189 | 25 | 4 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.56e-06 | 189 | 25 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 189 | 25 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.64e-06 | 190 | 25 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 190 | 25 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 190 | 25 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 190 | 25 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.71e-06 | 191 | 25 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-06 | 191 | 25 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-06 | 191 | 25 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-06 | 191 | 25 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.79e-06 | 192 | 25 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 192 | 25 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 192 | 25 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 192 | 25 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 192 | 25 | 4 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 192 | 25 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 193 | 25 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-06 | 193 | 25 | 4 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-06 | 193 | 25 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.87e-06 | 193 | 25 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 193 | 25 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 194 | 25 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-06 | 194 | 25 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.95e-06 | 194 | 25 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-06 | 194 | 25 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 194 | 25 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 194 | 25 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-06 | 194 | 25 | 4 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.95e-06 | 194 | 25 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.03e-06 | 195 | 25 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.03e-06 | 195 | 25 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.03e-06 | 195 | 25 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 195 | 25 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 195 | 25 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.03e-06 | 195 | 25 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 195 | 25 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 4.11e-06 | 196 | 25 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-06 | 196 | 25 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.11e-06 | 196 | 25 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.11e-06 | 196 | 25 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.11e-06 | 196 | 25 | 4 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 196 | 25 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.11e-06 | 196 | 25 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-06 | 197 | 25 | 4 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-06 | 197 | 25 | 4 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.20e-06 | 197 | 25 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Up 200; 11uM; HL60; HT_HG-U133A | 1.76e-06 | 198 | 24 | 5 | 6142_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 2208_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 3117_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.35e-05 | 200 | 24 | 4 | 4820_UP | |
| Drug | NSC 402447 | 1.25e-04 | 93 | 24 | 3 | CID006437335 | |
| Drug | Diphenhydramine | 1.43e-04 | 17 | 24 | 2 | ctd:D004155 | |
| Drug | aminochrome | 1.80e-04 | 19 | 24 | 2 | CID000170262 | |
| Drug | clevidipine | 2.00e-04 | 20 | 24 | 2 | CID000153994 | |
| Drug | AMPCPR | 2.35e-04 | 115 | 24 | 3 | CID000446724 | |
| Drug | biperiden | 2.66e-04 | 23 | 24 | 2 | CID000002381 | |
| Drug | p-Chloromercuribenzoic Acid | 2.87e-04 | 908 | 24 | 6 | ctd:D020245 | |
| Drug | Pam(3)CSK(4) peptide | 3.15e-04 | 25 | 24 | 2 | ctd:C508075 | |
| Drug | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 3.93e-04 | 137 | 24 | 3 | ctd:C090942 | |
| Drug | Span 20 | 4.25e-04 | 29 | 24 | 2 | CID000014926 | |
| Drug | isovalerate | 4.46e-04 | 143 | 24 | 3 | CID000010430 | |
| Drug | d4TMP | 5.18e-04 | 32 | 24 | 2 | CID000461278 | |
| Drug | trihexyphenidyl | 5.18e-04 | 32 | 24 | 2 | CID000005572 | |
| Drug | mercuric bromide | 7.10e-04 | 1076 | 24 | 6 | ctd:C042720 | |
| Drug | Leukotriene B4 | 7.71e-04 | 39 | 24 | 2 | ctd:D007975 | |
| Drug | Alpha-D-Mannose | 8.52e-04 | 41 | 24 | 2 | DB02944 | |
| Drug | T-Pg | 9.37e-04 | 43 | 24 | 2 | CID006323525 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 9.57e-04 | 186 | 24 | 3 | 5585_UP | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 5726_UP | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.00e-03 | 189 | 24 | 3 | 2695_UP | |
| Drug | Puromycin Aminonucleoside | 1.05e-03 | 192 | 24 | 3 | ctd:D011692 | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 4340_UP | |
| Disease | cytosolic non-specific dipeptidase measurement | 7.95e-06 | 6 | 22 | 2 | EFO_0020310 | |
| Disease | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform measurement | 7.95e-06 | 6 | 22 | 2 | EFO_0020637 | |
| Disease | BCL-2-like protein 1 measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0020177 | |
| Disease | uroplakin-3b-like protein measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0802204 | |
| Disease | kinesin-like protein KIF16B measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0801747 | |
| Disease | macrophage-stimulating protein receptor measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0020550 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 3 measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0020343 | |
| Disease | phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha measurement | 1.11e-05 | 7 | 22 | 2 | EFO_0801881 | |
| Disease | tumor necrosis factor receptor superfamily member 3 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0020813 | |
| Disease | stabilin-2 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0020752 | |
| Disease | desmoglein-1 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0020321 | |
| Disease | kallikrein-6 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0801739 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0801373 | |
| Disease | chromobox protein homolog 5 measurement | 1.48e-05 | 8 | 22 | 2 | EFO_0020258 | |
| Disease | epididymal-specific lipocalin-10 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0801576 | |
| Disease | mast cell-expressed membrane protein 1 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0801787 | |
| Disease | interleukin-34 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0020505 | |
| Disease | dickkopf-like protein 1 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0020324 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0801514 | |
| Disease | leucine-rich repeat serine/threonine-protein kinase 2 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0021876 | |
| Disease | cyclin-dependent kinase 5:cyclin-dependent kinase 5 activator 1 complex measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0020296 | |
| Disease | oxysterols receptor LXR-beta measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0801865 | |
| Disease | serine/threonine-protein kinase 16 measurement | 2.38e-05 | 10 | 22 | 2 | EFO_0020724 | |
| Disease | interleukin-37 measurement | 2.38e-05 | 10 | 22 | 2 | EFO_0020506 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.38e-05 | 10 | 22 | 2 | EFO_0801535 | |
| Disease | tropomyosin beta chain measurement | 2.38e-05 | 10 | 22 | 2 | EFO_0020787 | |
| Disease | insulin growth factor-like family member 3 measurement | 2.38e-05 | 10 | 22 | 2 | EFO_0801700 | |
| Disease | interleukin-10 receptor subunit alpha measurement | 2.91e-05 | 11 | 22 | 2 | EFO_0021890 | |
| Disease | guanylate-binding protein 6 measurement | 2.91e-05 | 11 | 22 | 2 | EFO_0801662 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.49e-05 | 12 | 22 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | oncostatin-M measurement | 3.49e-05 | 12 | 22 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 3.49e-05 | 12 | 22 | 2 | EFO_0020833 | |
| Disease | kallikrein-12 measurement | 4.12e-05 | 13 | 22 | 2 | EFO_0008194 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 5.54e-05 | 15 | 22 | 2 | DOID:655 (is_implicated_in) | |
| Disease | Pheochromocytoma, Extra-Adrenal | 6.33e-05 | 16 | 22 | 2 | C1257877 | |
| Disease | Pheochromocytoma | 9.00e-05 | 19 | 22 | 2 | C0031511 | |
| Disease | Bipolar Disorder | 3.92e-04 | 477 | 22 | 4 | C0005586 | |
| Disease | Multiple Sclerosis | 5.15e-04 | 45 | 22 | 2 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 5.15e-04 | 45 | 22 | 2 | C0751324 | |
| Disease | Neuroblastoma | 5.62e-04 | 47 | 22 | 2 | C0027819 | |
| Disease | hypertension (is_marker_for) | 7.15e-04 | 53 | 22 | 2 | DOID:10763 (is_marker_for) | |
| Disease | susceptibility to common cold measurement | 7.42e-04 | 54 | 22 | 2 | EFO_0008417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FYYFEHRSSKLPWPE | 446 | P06276 | |
| WHYFKGPSYSLRSTT | 476 | Q15389 | |
| WHSPYFFAYFPTASS | 71 | P20711 | |
| FDTVPYKNELYHWFP | 611 | P58397 | |
| YLEAYWKATHPPSSS | 456 | Q08289 | |
| PSYHPYWSTLYSFED | 376 | Q96M43 | |
| GHTPYSSYSEAWRFP | 406 | Q06710 | |
| YSSKYAPHSWPESRL | 731 | Q9HCI5 | |
| FYKPSFSWDTLATTY | 101 | Q5VTD9 | |
| SFDYSYWSHTSPEDP | 51 | O60333 | |
| APKSFTFDYSYWSHT | 46 | O43896 | |
| FFYTWPSPTSHLDKY | 256 | Q8NGB8 | |
| WEYPDTWSTPHSYFS | 256 | P29460 | |
| YFEPHSYFPQWIITK | 206 | Q8N878 | |
| FWKELSHLPSLYDYS | 276 | P10643 | |
| YIYDTRTSPPLWFHF | 291 | Q8NEP7 | |
| YSWSFPPYHPSSEKY | 151 | P22304 | |
| AFYPPHPDYTWSFDD | 251 | Q8NBJ5 | |
| LTFYPPHQDYTWTFD | 251 | Q8IYK4 | |
| TWYMSTLYSHPDFPE | 231 | P47712 | |
| PSYHPYWSTLYSFED | 376 | Q5VWK0 | |
| LPYALHKWSSFSSTY | 16 | Q9UL63 | |
| DYPPFFAWFEYILSH | 66 | Q9BVK2 | |
| SSYSPSLFWYVQHPN | 46 | A0A0B4J237 | |
| SFDSHRPYFTYWLTF | 396 | Q6PJF5 |